Get started Log in

SCYX — Scynexis Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Market Cap
$37.66m
Enterprise Value
-$16.42m
Revenue
$20.60m

Scynexis Inc Expected To Post A Loss Of 15 Cents A Share: Earnings Preview
03/11/2023 15:12
Brief: Scynexis reports Preclinical Data On Second Generation Fungerp SCY-247
24/10/2023 14:05
Brief: Scynexis Inc Says FDA Determined Compassionate Use Program For Ibrexafungerp Can Continue
02/10/2023 16:37
Brief: Scynexis Issues A Voluntary Nationwide Recall Of Brexafemme Due To Potential For Cross Contamination
28/09/2023 01:35
U.S. STOCKS ON THE MOVE-Starbucks, Williams-Sonoma, FedEx
25/09/2023 19:10
U.S. STOCKS ON THE MOVE-Soligenix, Enovis, Lifeway Foods
25/09/2023 17:50
Scynexis shares tumble on recall of antifungal drug
25/09/2023 14:24
Scynexis to recall GSK-partnered antifungal from market (updated)
25/09/2023 13:55
Scynexis to recall antifungal from market, pause studies
25/09/2023 13:45
Brief: Scynexis Inc Scynexis Is Recalling Brexafemme(Reg) (Ibrexafungerp Tablets) From Market
25/09/2023 13:37
U.S. STOCKS ON THE MOVE-Arcellx, U.S. Steel, Copper miners
15/08/2023 18:58
U.S. STOCKS ON THE MOVE-Getty Images, Tiziana, LL Flooring
15/08/2023 16:55
U.S. STOCKS ON THE MOVE-SCYNEXIS, Paysafe, Big banks
15/08/2023 14:32
Scynexis up on beating Q2 earnings
15/08/2023 12:42
Scynexis Inc Reports Results For The Quarter Ended In June: Earnings Summary
15/08/2023 24:07
Scynexis Inc Expected To Post Earnings Of $1.55 A Share: Earnings Preview
11/08/2023 15:20
Brief: Scynexis And Hansoh Pharma Announce Nmpa Acceptance Of New Drug Application For Ibrexafungerp In China
20/07/2023 15:45
Brief: Hansoh Pharmaceutical Says New Drug Application Of "Ibrexafungerp Tablets" Accepted By NMPA
20/07/2023 13:27
Brief: SCYNEXIS Announces Achievement Of First Development Milestone Of $25 Mln Under Exclusive License Agreement With GSK
21/06/2023 12:07
Brief: Stonepine Capital Management Reports 7.6% Passive Stake In Scynexis
09/06/2023 21:34